Position in ABEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,259
+$12,642 QoQ
Shares Held
9,433
+67.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Derivatives in ABEO
reported options exposure · as of Mar 31, 2026CallValue
$35,840
CallShares
8,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MAI Capital Management holds $16,329,886 across 273 Biotechnology names. ABEO ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,357 | $4,911,672 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,218 | $990,425 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
46,590 | $894,528 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
3,932 | $785,023 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
65,125 | $776,941 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
72,843 | $558,705 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,477 | $406,641 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,209 | $400,021 |
All Filings in ABEO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,840 | 8,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $42,259 | 9,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,617 | 5,620 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $21,080 | 4,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $8,553 | 1,620 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,201 | 1,620 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,711 | 1,620 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||